Poster Sessions in the T-state (inactive; NADH bound). Notably, in the unregulated Type I CS these same residues form a stable folded region composed of two large helices that are a key part of the binding site for acetylCoA. Kinetic analyses of both types of CS indicate a similar catalytic mechanism, suggesting that in the active R-state of E. coli Type II CS, the conformation of residues 262-298 will be similar to that seen in the unregulated Type I enzymes. This uniquely evolved functionality switch in the Type II CS provides the opportunity to study a novel aspect of the protein folding problem, namely how to engineer the property of reversible instability into a formerly stably folded region. We have specifically designed and determined the structures of variant enzymes to gain a better understanding of the mechanistic features of this allosterically controlled regulatory folding/unfolding system. This has resulted in a series of stepwise structural snap shots of the refolding process in going from the T to R- Human membrane integrated protein is one of the most exciting target for protein crystallographers, due to the difficulties in protein preparation as well as crystallographic work. In the year 2007, the structures of three human membrane proteins were determined crystallographically first. Leukotriene C4 synthase (LTC4S) is one of the three human membrane integrated proteins. LTC4S, which is a membrane integrated protein existing in nuclear membrane, catalyzes the conjugation between leukotriene (LT) A4 and glutathione (GSH) to form LTC4. LTC4 and its metabolites LTD4 and LTE4 are components of slow reacting substance of anaphylaxis, and they are called cysteinyl leukotrienes (Cys-LTs) because they have a cysteine moiety commonly. Cys-LTs are lipid mediators involved in smooth muscle constriction and inflammation, particularly in asthma. LTC4S is the membrane protein responsible for the biosynthesis of Cys-LTs and a potential target for drug discovery. The crystal structure of human LTC4S was determined at 3.3Å resolution using the recombinant LTC4S. We established the over-expression system using Schizosaccharomyces pombe, and we also used the expression system for the preparation of the selenomethionine derivative of LTC4S with a Leu121Met mutation for the MAD phase calculation as well as the native LTC4S with a histidine tag. In the crystal structure LTC4S forms trimer structure, and there is a V-shape substrate binding cleft between two adjacent monomers. GSH, which is one of the substrates, was co-crystallized with LTC4S, bound at the upper space of the V-shape cleft. Based on the crystal structure, we proposed the acid-base catalytic mechanism, and Arg31 from a monomer and Arg104 from the other monomer exert the acid and base, respectively. Oligo-1,6-glucosidase (dextrin 6-α-D-glucanohydrolase; EC 3.2.1.10) generally hydrolyzes nonreducing terminal α -1,6-glucosidic bonds of isomaltooligosaccharides and α-limit dextrin more rapidly than those of isomaltose. However, oligo-1,6-glucosidase from Saccharomyces cerevisiae (isomaltase) preferentially hydrolyzes isomaltose and weakly acts on isomaltooligosaccharides. To understand the difference in substrate specificity between isomaltase and other oligo-1,6-glucosidase from a structural view point, the crystal structure of isomaltase and isomaltase complexed with maltose as a competitive inhibitor were determined. Isomaltase was crystallized by the hanging drop vapor diffusion method using PEG3350 as a precipitant. An inhibitor complex was cocrystallized under the same conditions in the presence of 0.2 M maltose. Data sets for structural analysis were collected on synchrotron radiation to 1.6 Å resolution for the native and maltose complex. The crystals belong to the monoclinic space group C2 with the cell dimensions a=95.7 Å, b=115.4 Å, c=61.8 Å, β=91.2 o and one 67 kDa molecule per asymmetric unit. The Overall structural features of isomaltase are similar to those of other GH family 13 enzymes such as α-amylases and Bacillus cereus oligo-1,6-glucosidase. It consists of three domains containing a (β/α)8 barrel structure. This reveals that the entrance of the active site cleft is narrowed by Tyr158, His280, and a loop between 310 to 315, thus disaccharide binds most efficiently in the active site for hydrolysis. The glucose residue of the nonreducing end is buried deeply at the bottom of the cleft, and tightly bound by nine hydrogen bonds and a stacking interaction with Tyr72. However, no structural change is observed before and after maltose binding.
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Crystal structures of -amino--caprolactam racemase from Achromobacter obae Nagoya University, Department of Biotechnology, School of Engineering, Fur-cho, Chikusa, Nagoya, Aichi Prefecture, 464-8603, Japan, 2 Nagoya University, Fur-cho, Chikusa, Nagoya, Aichi Prefecture, 464-8603, Japan, 3 Nagoya University, Fur-cho, Chikusa, Nagoya, Aichi Prefecture, 464-8603, Japan, 4 Toyama Prefectural University, Kurokawa 5180, Imizu, Toyama Prefecture, 939-0398, Japan, 5 Toyama Prefectural University, Kurokawa 5180, Imizu, Toyama Prefecture, 939-0398, Japan, 6 Nagoya University, Fur-cho, Chikusa, Nagoya, Aichi Prefecture, 464-8603, Japan, E-mail okazaki.seiji@d.mbox.nagoya-u.ac.jp α-Amino-ε -caprolactam (ACL) racemase (EC 5.1.1.15) is a 51 kDa enzyme that catalyzes the interconversion of L-and D-ACL. Recently, amino acid amide racemizing activity was found in ACL racemase [1] , and the combined method of ACL racemase with D-stereospecific amino acid amidase has been developed for industrial D-amino acid production from D,L-amino acid amide [2] . To clarify the structute-function relationships of ACL racemase, the crystal structures of the native and ε -caprolactam complex of ACL racemase were determined at 2.3 and 2.4 Å resolutions, respectively. ACL racemase belongs to the fold-type 1 group of PLP-dependent enzyme [3] . The crystal structures of serine racemase which belongs to fold-type 2 (PDB ID 1V71) and alanine racemase which belongs to fold-type 3(1SFT) were already determined. However, the crystal structure of fold-type 1 racemase has not been determined yet. If the structure of ACL racemase can be determined, we can understand the catalytic mechanism of racemase which belongs to fold-type 1 for the first time. The structure of ACL racemase is composed of three segments; (1) an N-terminal segment, (2) a large, pyridoxal phosphate (PLP) binding domain and (3) a C-terminal domain. The C4¸ in PLP covalently bonded to the ε -amino group of Lys267 forming the internal aldimine. From structural comparison with racemase belongs to fold-type 2 and 3, Lys267 and Tyr137 of ACL racemase may be candidates for two bases which are essential for proceeding racemization. The functional significance of ACL racemase will be discussed. FBPase (Fructose-1,6-bis-phosphatase) is a key enzyme in gluconeogenesis. Together with its counterpart enzyme in glycolysis, Phosphofructokinase, FBPase regulates glucose metabolism. FBPase forms a tetramer that is allosterically inhibited by AMP. The allosteric transition from the active R-state to the inactive T-state was intensely investigated over the last 20 years both biochemically and structurally and now serves as a textbook example for allosteric regulation in proteins. However, structural knowledge on FBPase stems almost exclusively from pig kidney/liver FBPase and thus may be biased toward this organism. Muscle FBPase is reported to be 100-fold more sensitive to AMP inhibition than liver FBPase while rodent liver FBPases are roughly 10-fold less sensitive to allosteric inhibition than their human or pig counterparts. Do the textbooks convey the correct picture of the allosteric transition? Or do they purport a biased and, thus, misleading view of the pig special case? To clarify this issue we determined several crystal structures of FBPase liver and muscle isoforms from rat, mouse, and human. 
